This is a Phase 3, multi-center, randomized, placebo-controlled trial to determine the
effectiveness and safety of the 6% cellulose sulfate (CS) vaginal gel for the prevention of
HIV infection.
Phase:
Phase 3
Details
Lead Sponsor:
FHI 360
Collaborators:
Lagos State University University of Port Harcourt Teaching Hospital